Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|September 11, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the WeekWout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, et al.
The American Journal of Pathology|November 21, 2017
Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery DiseaseSaranya Ravi, Robert N Schuck, Eleanor Hilliard, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Impact of Pregnancy on the Pharmacokinetics and Metabolism of Nicotinamide in HumansMuluneh M Fashe, Tien V Le, Megan N Gower, et al.
Pharmacogenetics and Genomics|February 16, 2007
Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1)Craig R Lee, Frank G Bottone, Joseph M Krahn, et al.
Pharmacotherapy|December 31, 2008
High-impact articles related to the management of heart failure: 2008 updateCynthia A Jackevicius, Robert L Page, Sheryl Chow, et al.
Prostaglandins & Other Lipid Mediators|September 25, 2012
Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in miceAkinyemi Oni-Orisan, Yangmei Deng, Robert N Schuck, et al.
Pharmacotherapy|November 13, 2004
High-impact articles related to the pharmacotherapeutic management of systolic heart failureTien M H Ng, Orly Carter, Gregory S Guillory, et al.
Pharmacogenetics and Genomics|November 17, 2006
NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities studyCraig R Lee, Kari E North, Molly S Bray, et al.
The Journal of Clinical Investigation|January 24, 2017
Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA bindingXue Bai, Kevin D Mangum, Rachel A Dee, et al.
Pharmacogenomics|April 1, 2015
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patientsJohn Andrew Lee, Craig R Lee, Brent N Reed, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|September 11, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the WeekWout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, et al.
The American Journal of Pathology|November 21, 2017
Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery DiseaseSaranya Ravi, Robert N Schuck, Eleanor Hilliard, et al.
Clinical Pharmacology and Therapeutics|December 14, 2023
Impact of Pregnancy on the Pharmacokinetics and Metabolism of Nicotinamide in HumansMuluneh M Fashe, Tien V Le, Megan N Gower, et al.
Pharmacogenetics and Genomics|February 16, 2007
Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1)Craig R Lee, Frank G Bottone, Joseph M Krahn, et al.
Pharmacotherapy|December 31, 2008
High-impact articles related to the management of heart failure: 2008 updateCynthia A Jackevicius, Robert L Page, Sheryl Chow, et al.
Prostaglandins & Other Lipid Mediators|September 25, 2012
Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in miceAkinyemi Oni-Orisan, Yangmei Deng, Robert N Schuck, et al.
Pharmacotherapy|November 13, 2004
High-impact articles related to the pharmacotherapeutic management of systolic heart failureTien M H Ng, Orly Carter, Gregory S Guillory, et al.
Pharmacogenetics and Genomics|November 17, 2006
NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities studyCraig R Lee, Kari E North, Molly S Bray, et al.
The Journal of Clinical Investigation|January 24, 2017
Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA bindingXue Bai, Kevin D Mangum, Rachel A Dee, et al.
Pharmacogenomics|April 1, 2015
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patientsJohn Andrew Lee, Craig R Lee, Brent N Reed, et al.
Pageof 13